Given the finding that genetic indexing of PCSK9 inhibition predicted higher AD risk in our main models, we further examined whether differences in exposure to circulating PCSK9 may be related to AD risk using MR, and compared these results to the predicted effect of circulating PCSK9 variation on CAD (Table 3). The gene discussed is PCSK9; the disease is coronary artery disorder.